FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068082904> ?p ?o ?g. }

• W2068082904 endingPage "136" @default.
• W2068082904 startingPage "129" @default.
• W2068082904 abstract "This study was undertaken to identify novel approaches to pharmacological treatment of asthma. Here we hypothesize that the platelet-activating factor receptor antagonist ginkgolide B (GB) in combination with the antioxidant carotenoid astaxanthin (ASX) suppresses T cell activation comparably to two commonly-used antihistamines: cetirizine dihydrochloride (CTZ) and azelastine (AZE). Peripheral blood mononuclear cells from asthmatics, cultured 24 h with either 50 microg/ml phytohemaglutinin (PHA) or PHA plus selected dosages of each drug are analyzed by flow cytometry for CD25+ or HLA-DR+ on CD3+ (T cells). Results are reported as stimulation indices (SI) of %CD3+CD25+ cells or %CD3+HLA-DR+ cells in cultures treated with PHA alone versus these subpopulations in cultures treated with both PHA and drugs. Combinations of ASX and GB exhibited optimal suppression at 10(-7) M GB + 10(-8) M ASX for CD3+CD25+ (SI = 0.79 +/- 0.04, P = 0.001) and 10(-7) M GB + 10(-7) M ASX for CD3+HLA-DR+ (SI = 0.82 +/- 0.05, P = 0.004). In conclusion, suppression of T cell activation below fully stimulated values by GB, ASX, and their combinations was comparable and for some combinations better than that mediated by CTZ and AZE. These results suggest that ASX and GB may have application as novel antiasthmatic formulations." @default.
• W2068082904 created "2016-06-24" @default.
• W2068082904 creator A5008582535 @default.
• W2068082904 creator A5009758908 @default.
• W2068082904 creator A5015955382 @default.
• W2068082904 creator A5038797092 @default.
• W2068082904 creator A5055935259 @default.
• W2068082904 creator A5060377830 @default.
• W2068082904 date "2004-01-01" @default.
• W2068082904 modified "2023-10-14" @default.
• W2068082904 title "In Vitro Effects of Astaxanthin Combined With Ginkgolide B on T Lymphocyte Activation in Peripheral Blood Mononuclear Cells From Asthmatic Subjects" @default.
• W2068082904 cites W1985327082 @default.
• W2068082904 cites W1988227673 @default.
• W2068082904 cites W1991869743 @default.
• W2068082904 cites W1993705126 @default.
• W2068082904 cites W1999996389 @default.
• W2068082904 cites W2025029128 @default.
• W2068082904 cites W2027498736 @default.
• W2068082904 cites W2041803663 @default.
• W2068082904 cites W2042002770 @default.
• W2068082904 cites W2058640545 @default.
• W2068082904 cites W2062935085 @default.
• W2068082904 cites W2068030500 @default.
• W2068082904 cites W2084814678 @default.
• W2068082904 cites W2085840704 @default.
• W2068082904 cites W2090799155 @default.
• W2068082904 cites W2091756509 @default.
• W2068082904 cites W2095245744 @default.
• W2068082904 cites W2107324945 @default.
• W2068082904 cites W2129872180 @default.
• W2068082904 cites W2137881296 @default.
• W2068082904 cites W2146873810 @default.
• W2068082904 cites W2149358970 @default.
• W2068082904 cites W2150029274 @default.
• W2068082904 cites W2335272589 @default.
• W2068082904 cites W4231271763 @default.
• W2068082904 cites W4253732216 @default.
• W2068082904 cites W2094784770 @default.
• W2068082904 doi "https://doi.org/10.1254/jphs.94.129" @default.
• W2068082904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14978350" @default.
• W2068082904 hasPublicationYear "2004" @default.
• W2068082904 type Work @default.
• W2068082904 sameAs 2068082904 @default.
• W2068082904 citedByCount "23" @default.
• W2068082904 countsByYear W20680829042012 @default.
• W2068082904 countsByYear W20680829042013 @default.
• W2068082904 countsByYear W20680829042017 @default.
• W2068082904 countsByYear W20680829042020 @default.
• W2068082904 countsByYear W20680829042021 @default.
• W2068082904 countsByYear W20680829042022 @default.
• W2068082904 countsByYear W20680829042023 @default.
• W2068082904 crossrefType "journal-article" @default.
• W2068082904 hasAuthorship W2068082904A5008582535 @default.
• W2068082904 hasAuthorship W2068082904A5009758908 @default.
• W2068082904 hasAuthorship W2068082904A5015955382 @default.
• W2068082904 hasAuthorship W2068082904A5038797092 @default.
• W2068082904 hasAuthorship W2068082904A5055935259 @default.
• W2068082904 hasAuthorship W2068082904A5060377830 @default.
• W2068082904 hasBestOaLocation W20680829041 @default.
• W2068082904 hasConcept C114684123 @default.
• W2068082904 hasConcept C137061746 @default.
• W2068082904 hasConcept C153911025 @default.
• W2068082904 hasConcept C154317977 @default.
• W2068082904 hasConcept C167672396 @default.
• W2068082904 hasConcept C185592680 @default.
• W2068082904 hasConcept C202751555 @default.
• W2068082904 hasConcept C203014093 @default.
• W2068082904 hasConcept C2780962900 @default.
• W2068082904 hasConcept C28781525 @default.
• W2068082904 hasConcept C553184892 @default.
• W2068082904 hasConcept C55493867 @default.
• W2068082904 hasConcept C71924100 @default.
• W2068082904 hasConcept C79484868 @default.
• W2068082904 hasConcept C86803240 @default.
• W2068082904 hasConcept C8891405 @default.
• W2068082904 hasConcept C98274493 @default.
• W2068082904 hasConceptScore W2068082904C114684123 @default.
• W2068082904 hasConceptScore W2068082904C137061746 @default.
• W2068082904 hasConceptScore W2068082904C153911025 @default.
• W2068082904 hasConceptScore W2068082904C154317977 @default.
• W2068082904 hasConceptScore W2068082904C167672396 @default.
• W2068082904 hasConceptScore W2068082904C185592680 @default.
• W2068082904 hasConceptScore W2068082904C202751555 @default.
• W2068082904 hasConceptScore W2068082904C203014093 @default.
• W2068082904 hasConceptScore W2068082904C2780962900 @default.
• W2068082904 hasConceptScore W2068082904C28781525 @default.
• W2068082904 hasConceptScore W2068082904C553184892 @default.
• W2068082904 hasConceptScore W2068082904C55493867 @default.
• W2068082904 hasConceptScore W2068082904C71924100 @default.
• W2068082904 hasConceptScore W2068082904C79484868 @default.
• W2068082904 hasConceptScore W2068082904C86803240 @default.
• W2068082904 hasConceptScore W2068082904C8891405 @default.
• W2068082904 hasConceptScore W2068082904C98274493 @default.
• W2068082904 hasIssue "2" @default.
• W2068082904 hasLocation W20680829041 @default.
• W2068082904 hasLocation W20680829042 @default.
• W2068082904 hasOpenAccess W2068082904 @default.
• W2068082904 hasPrimaryLocation W20680829041 @default.

• next